Goldkorn A - Search Results

1

Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer.

Goldkorn A, Ely B, Quinn DI, Tangen CM, Fink LM, Xu T, Twardowski P, Van Veldhuizen PJ, Agarwal N, Carducci MA, Monk JP 3rd, Datar RH, Garzotto M, Mack PC, Lara P Jr, Higano CS, Hussain M, Thompson IM Jr, Cote RJ, Vogelzang NJ. Goldkorn A, et al. J Clin Oncol. 2014 Apr 10;32(11):1136-42. doi: 10.1200/JCO.2013.51.7417. Epub 2014 Mar 10. J Clin Oncol. 2014. PMID: 24616308 Free PMC article. Clinical Trial.

2

Reprogramming murine telomerase rapidly inhibits the growth of mouse cancer cells in vitro and in vivo.

Xu T, Xu Y, Liao CP, Lau R, Goldkorn A. Xu T, et al. Among authors: goldkorn a. Mol Cancer Ther. 2010 Feb;9(2):438-49. doi: 10.1158/1535-7163.MCT-09-0682. Epub 2010 Feb 2. Mol Cancer Ther. 2010. PMID: 20124445 Free PMC article.

3

A cancer detection platform which measures telomerase activity from live circulating tumor cells captured on a microfilter.

Xu T, Lu B, Tai YC, Goldkorn A. Xu T, et al. Among authors: goldkorn a. Cancer Res. 2010 Aug 15;70(16):6420-6. doi: 10.1158/0008-5472.CAN-10-0686. Epub 2010 Jul 27. Cancer Res. 2010. PMID: 20663903 Free PMC article.

4

Prostate tumor cells with cancer progenitor properties have high telomerase activity and are rapidly killed by telomerase interference.

Xu T, He K, Wang L, Goldkorn A. Xu T, et al. Among authors: goldkorn a. Prostate. 2011 Sep 15;71(13):1390-400. doi: 10.1002/pros.21355. Epub 2011 Feb 14. Prostate. 2011. PMID: 21321978 Free PMC article.

5

Cancer cells cyclically lose and regain drug-resistant highly tumorigenic features characteristic of a cancer stem-like phenotype.

He K, Xu T, Goldkorn A. He K, et al. Among authors: goldkorn a. Mol Cancer Ther. 2011 Jun;10(6):938-48. doi: 10.1158/1535-7163.MCT-10-1120. Epub 2011 Apr 25. Mol Cancer Ther. 2011. PMID: 21518726 Free PMC article.

6

Targeted therapy in renal cancer.

Dorff TB, Goldkorn A, Quinn DI. Dorff TB, et al. Among authors: goldkorn a. Ther Adv Med Oncol. 2009 Nov;1(3):183-205. doi: 10.1177/1758834009349119. Ther Adv Med Oncol. 2009. PMID: 21789121 Free PMC article.

7

Telomerase targeted therapy in cancer and cancer stem cells.

Xu Y, He K, Goldkorn A. Xu Y, et al. Among authors: goldkorn a. Clin Adv Hematol Oncol. 2011 Jun;9(6):442-55. Clin Adv Hematol Oncol. 2011. PMID: 21841744 Review.

8

Perillyl alcohol for the treatment of temozolomide-resistant gliomas.

Cho HY, Wang W, Jhaveri N, Torres S, Tseng J, Leong MN, Lee DJ, Goldkorn A, Xu T, Petasis NA, Louie SG, Schönthal AH, Hofman FM, Chen TC. Cho HY, et al. Among authors: goldkorn a. Mol Cancer Ther. 2012 Nov;11(11):2462-72. doi: 10.1158/1535-7163.MCT-12-0321. Epub 2012 Aug 28. Mol Cancer Ther. 2012. PMID: 22933703

9

Cancer cells acquire a drug resistant, highly tumorigenic, cancer stem-like phenotype through modulation of the PI3K/Akt/β-catenin/CBP pathway.

He K, Xu T, Xu Y, Ring A, Kahn M, Goldkorn A. He K, et al. Among authors: goldkorn a. Int J Cancer. 2014 Jan 1;134(1):43-54. doi: 10.1002/ijc.28341. Epub 2013 Aug 5. Int J Cancer. 2014. PMID: 23784558

10

Therapeutic windows and opportunity cost cast upon prostate cancer's fatal shore.

Goldkorn A, Aparicio AM, Quinn DI. Goldkorn A, et al. Ann Oncol. 2013 Jul;24(7):1717-1720. doi: 10.1093/annonc/mdt234. Ann Oncol. 2013. PMID: 23798673 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters